World
World · FDA WARNING
The FDA is requiring Ozempic, Wegovy, Mounjaro, Zepbound and all other GLP-1 drugs to carry a warning about NAION, a rare optic…
The FDA is requiring Ozempic, Wegovy, Mounjaro, Zepbound and all other GLP-1 drugs to carry a warning about NAION, a rare optic nerve condition that can cause sudden, permanent vision loss.
